Skip to main content
OpenTrials
Completed

NCT Number: NCT04494841

Usability of a Multimodal External Neuromodulatory Device to Relieve Acute Low Back Pain

Ten patients with acute or chronic low back pain will be invited to try a multimodal device for 20 minutes. Pain will be recorded prior to and after use, and feedback on the device will be elicited.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sport and Spine Rehab Clinic

Rockville, Maryland, 20852, United States

About this study

To facilitate data collection of a short-term intervention, the investigators chose to enroll patients from a mixed physical therapy/chiropractic practice with demographic and economic diversity in the metro Washington area. The neuromodulatory device will have patient controlled frequencies at 50Hz, 100Hz, and 180Hz attached to a 12 x 22 cm metal plate ergonomically curved to fit the low back. The device will be wearable with a neoprene belt on both sides for patients to adjust pressure. The metal pocket in our device holds a 221g clay pack capable of being frozen to 15F or heated to 110F or patient tolerance, with 30 minute thermal capacity. A convenience sample of 10 patients at the clinic was invited to give feedback on the prototype device after informed consent. Changes suggested were incorporated and after informed consent a second group of ten gave will give feedback with the production-ready device.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acute or chronic low back pain as chief complaint
  • Capacity to understand all relevant risks and potential benefits of the study (informed consent);
  • Willingness to communicate information

Exclusion criteria

  • Radicular pain likely reflecting a surgical or mechanical problem
  • BMI greater than 30 (device won't fit)
  • Sensitivity to cold or vibration (e.g Raynaud's or Sickle Cell Disease)
  • Diabetic neuropathy rendering a patient unable to determine if the device is too hot
  • New neurologic deficits
  • Skin lesions over the low back area
  • Contraindication to any medication for pain management that would impact analgesic use record
  • Inability to apply DuoTherm

Treatment and study plan

Duotherm VibraCool Back Device

Device

Low back plate belt with mechanicothermal and pressure intervention options.

Primary outcomes

  1. Change in Pain: Visual Analog Scale (VAS)

    Time frame: Before use of device (baseline) and after use of device approximately 30 minutes - 20 minutes of use, with 10 minutes for evaluation

    Difference in 10 cm VAS printed on paper from 0 (no pain) to 10 (most pain) before and after use of the device, higher value indicates a greater pain reduction, 1.8 cm is considered clinically relevant.

  2. Participants' Choice in Thermal Options

    Time frame: 30 minutes

    One of four options: hot, cold, none, both

  3. Would You Recommend

    Time frame: After 30 minutes

    Binary approval or disapproval of device

Secondary outcomes

  1. Subjective Pain Relief

    Time frame: 30 minutes

    7-item Likert scale of 1 (much worse) to 7 (much better) pain relief over the time of the study

Sponsors and collaborators

Lead sponsor

MMJ Labs LLC

Industry

Collaborators

  • National Institute on Drug Abuse (NIDA)
  • Sport and Spine Rehab Clinical Research Foundation

Registry information

Official study title

Addressing Feasibility of the DuoTherm in Acute and Chronic Low Back Pain

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Jul 31, 2020
Registry last updated
Oct 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.